Trial of Metformin | 農藥百科
2022年4月26日—TrialofMetformin-ClemastineComboEnrollsFirstPatient.MarisaWexler,MSavatar.byMarisaWexler,MS|April26,2022 ...
The first participant has been enrolled in a new clinical trial that is testing whether an antihistamine in combination with a diabetes medication might promote the repair of the myelin sheath in people with multiple sclerosis[1] (MS).
The trial’s first participant, Annabelle, was diagnosed with relapsing MS over a decade ago.
“I was so inspired when I saw the clinical trial and signed up straight away… just a few months ago I was told there was nothing I could do — now I’m the first participant on a new trial! It’s given me so much hope,” Annabelle said in a press release[2] from the U.K.’s MS Society[3].
“The recruitment of our first participant is a huge milestone. We’re another step closer to a time where a person with MS will be given a handful of treatments to tackle all the different elements of MS, so that their life will be minimally affected by the con...